Bristol-Myers Squibb Company PFD CONV 2 (BMYMP)
USD 998.89
(0.0%)
USD 998.89
(0.0%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | 13.86 Billion | 13.06 Billion | 16.2 Billion | 14.05 Billion | 8.06 Billion | 5.94 Billion |
| Net Income | 8.04 Billion | 6.34 Billion | 7.01 Billion | -8.99 Billion | 3.46 Billion | 4.94 Billion |
| Depreciation & Amortization | 9.76 Billion | 10.27 Billion | 10.68 Billion | 10.38 Billion | 1.74 Billion | 637 Million |
| Deferred income taxes | -3.28 Billion | -2.73 Billion | -1.39 Billion | 983 Million | -924 Million | 86 Million |
| Stock-based compensation | 518 Million | 457 Million | 583 Million | 779 Million | 441 Million | 221 Million |
| Change in working capital | -1.91 Billion | -2.22 Billion | -1.25 Billion | 983 Million | 3.06 Billion | 176 Million |
| Other non-cash items | 744 Million | 955 Million | 570 Million | 9.92 Billion | 279 Million | -127 Million |
| Investing Cash Flow | -2.29 Billion | -1.06 Billion | -538 Million | -10.85 Billion | -9.77 Billion | -874 Million |
| Investments in PPE | -1.2 Billion | -1.11 Billion | -973 Million | -753 Million | -836 Million | -951 Million |
| Acquisitions | -260 Million | -2.98 Billion | -862 Million | -12.21 Billion | -8.78 Billion | 3 Million |
| Investment purchases | -1.77 Billion | -3.59 Billion | -5.47 Billion | -4.17 Billion | -3.96 Billion | -2.3 Billion |
| Sales/Maturities of investments | 948 Million | 6.62 Billion | 6.77 Billion | 6.28 Billion | 3.8 Billion | 2.37 Billion |
| Other Investing Activities | 909 Million | 1.3 Billion | - | - | - | - |
| Financing Cash Flow | -9.41 Billion | -16.96 Billion | -16.22 Billion | -1.15 Billion | 7.62 Billion | -3.53 Billion |
| Debt repayment | -456 Million | -11.43 Billion | -6.02 Billion | -2.75 Billion | -9.25 Billion | -5 Million |
| Dividends payments | -4.74 Billion | -4.63 Billion | -4.39 Billion | -4.07 Billion | -2.67 Billion | -2.61 Billion |
| Common Stock Repurchased | -5.15 Billion | -8 Billion | -6.28 Billion | -1.54 Billion | -7.3 Billion | -320 Million |
| Common Stock Issuance | - | - | -160 Million | 6.67 Billion | 26.9 Billion | -543 Million |
| Other Financing Activities | 27 Million | 7.1 Billion | 641 Million | 542 Million | -53 Million | -54 Million |
| Accounts receivables | -995 Million | -663 Million | -2.11 Billion | -2.95 Billion | 1.65 Billion | -267 Million |
| Accounts payables | 198 Million | 109 Million | 245 Million | 188 Million | 229 Million | -59 Million |
| Inventory | -751 Million | -69 Million | 13 Million | 2.67 Billion | 463 Million | -216 Million |
| Other working capital | -366 Million | -1.6 Billion | 606 Million | 1.07 Billion | 714 Million | 718 Million |
| Cash at beginning of period | 9.32 Billion | 14.31 Billion | 14.97 Billion | 12.82 Billion | 6.91 Billion | 5.42 Billion |
| Cash at end of period | 11.51 Billion | 9.32 Billion | 14.31 Billion | 14.97 Billion | 12.82 Billion | 6.91 Billion |
| Capital Expenditure | -1.2 Billion | -1.11 Billion | -973 Million | -753 Million | -836 Million | -951 Million |
| Effect of forex changes on cash | 45 Million | -33 Million | -102 Million | 111 Million | -9 Million | -41 Million |
| Net cash flow / Change in cash | 2.19 Billion | -4.99 Billion | -657 Million | 2.15 Billion | 5.9 Billion | 1.49 Billion |
| Free Cash Flow | 12.65 Billion | 11.94 Billion | 15.23 Billion | 13.29 Billion | 7.23 Billion | 4.98 Billion |
| Breakdown | 2024 Q3 | 2024 Q2 | 2024 Q1 | 2023 FY | 2023 Q4 | 2023 Q3 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | 1.21 Billion | 1.68 Billion | -11.9 Billion | 8.04 Billion | 1.76 Billion | 1.93 Billion |
| Depreciation & Amortization | 2.62 Billion | 2.56 Billion | 2.53 Billion | 9.76 Billion | 2.46 Billion | 2.43 Billion |
| Deferred income taxes | -256 Million | -331 Million | -711 Million | -3.28 Billion | -1.32 Billion | -327 Million |
| Stock-based compensation | 129 Million | 125 Million | 133 Million | 518 Million | 127 Million | 132 Million |
| Change in working capital | 2.17 Billion | -2.37 Billion | 198 Million | -1.91 Billion | 855 Million | 291 Million |
| Other non-cash items | -301 Million | 7.41 Billion | 12.97 Billion | 744 Million | 371 Million | 286 Million |
| Investing Cash Flow | -219 Million | -1.31 Billion | -19.61 Billion | -2.29 Billion | -1.34 Billion | -410 Million |
| Investments in PPE | -324 Million | -262 Million | -284 Million | -1.2 Billion | -330 Million | -342 Million |
| Acquisitions | -859 Million | -1.1 Billion | -19.81 Billion | -260 Million | -340 Million | -79 Million |
| Investment purchases | -40 Million | -84 Million | -274 Million | -1.77 Billion | -717 Million | -502 Million |
| Sales/Maturities of investments | 238 Million | 130 Million | 752 Million | 948 Million | 41 Million | 513 Million |
| Other Investing Activities | 766 Million | -262 Million | 241 Million | 909 Million | 909 Million | - |
| Financing Cash Flow | -3.85 Billion | -4.02 Billion | 14.64 Billion | -9.41 Billion | 967 Million | -5.16 Billion |
| Debt repayment | -18.75 Billion | -2.8 Billion | -15.95 Billion | -456 Million | -2.1 Billion | -10 Million |
| Dividends payments | -1.21 Billion | -1.21 Billion | -1.21 Billion | -4.74 Billion | -1.16 Billion | -1.19 Billion |
| Common Stock Repurchased | - | - | - | -5.15 Billion | - | -4 Billion |
| Common Stock Issuance | - | - | - | - | -10 Million | - |
| Other Financing Activities | 16.11 Billion | -6 Million | 15.85 Billion | 27 Million | 25 Million | 41 Million |
| Accounts receivables | 661 Million | -1.01 Billion | 479 Million | -995 Million | 536 Million | -659 Million |
| Accounts payables | -374 Million | -259 Million | 300 Million | 198 Million | 444 Million | -268 Million |
| Inventory | -218 Million | -225 Million | -218 Million | -751 Million | -197 Million | -256 Million |
| Other working capital | 2.14 Billion | -868 Million | -1.27 Billion | -366 Million | 72 Million | 1.47 Billion |
| Cash at beginning of period | 6.29 Billion | 9.33 Billion | 11.51 Billion | 9.32 Billion | 7.56 Billion | 8.42 Billion |
| Cash at end of period | 7.89 Billion | 6.29 Billion | 9.33 Billion | 11.51 Billion | 11.51 Billion | 7.56 Billion |
| Capital Expenditure | -324 Million | -262 Million | -284 Million | -1.2 Billion | -330 Million | -342 Million |
| Effect of forex changes on cash | 77 Million | -22 Million | -45 Million | 45 Million | 78 Million | -38 Million |
| Net cash flow / Change in cash | 1.59 Billion | -3.03 Billion | -2.18 Billion | 2.19 Billion | 3.95 Billion | -857 Million |
| Free Cash Flow | 5.26 Billion | 2.06 Billion | 2.55 Billion | 12.65 Billion | 3.92 Billion | 4.4 Billion |
002044
3540
2458
QCA
1926
2426